Pharmaceuticals

Drug Recall: Q&A with Beth Riggio

bexib
By bexib 0 Min Read

Beth Riggio, Vice President of Product Management, Global Products and Solutions at Cencora, discusses the challenges the industry faces with recalls and how to improve them.

You Might Also Like

APL and CurifyLabs Partner to Support Patients with 3D Printed Medical Technology

Phase 2 PREDICT-ILD Imaging Study in Interstitial Lung Disease Begins

New ways to determine drug value with health equity in mind

Melissa Krebs Shares Gersana’s Vision for Innovative Wound Care Solutions

Zongertinib demonstrates high objective response rates in previously treated advanced non-small cell lung cancer

Share This Article
Previous Article How AI improves keyword research
Next Article What’s happening at Belgian ports should worry American automakers and policymakers
Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Processing superalloys while cooling them
Manufacturing
Carlowley Castle announces new venture redefining luxury hospitality, opening doors to Scotland’s luxury estates
Hospitality & Tourism
Fintech funding will “stabilize” in 2025, venture capital prioritizes AI fintech
Banking
6 amazing projects from 2024
Manufacturing